(Q40522806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Christine Ménétrier-Caux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

Nathalie Bendriss-Vermare

4 January 2020

5

object named as

Nathalie Bendriss-Vermare

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

Isabelle Ray-Coquard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

7

Catherine Sebban

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

4

Gilles Clapisson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Christophe Borg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Irene Philip

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Pierre Biron

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

2675-2680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15503313%20AND%20SRC:MED&resulttype=core&format=json

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Changing paradigms in the management of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

PNEUMOCYSTIS CARINII INFECTION COMPLICATING CYTOTOXIC THERAPY IN TWO PATIENTS WITH LYMPHOPENIA, BUT A NORMAL TOTAL WHITE CELL COUNT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20688

7 January 2021